SCHEMBL1860158

SCHEMBL1860158

[CH2]CCN1CC(OC(=O)O)C1

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CHRM4 P08173 1/20 0.31
CHRM3 P20309 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1859299 0.85 CHRM3 (0.37) CHRM4CHRM3
SCHEMBL1855721 0.83 ATM (0.31)
SCHEMBL1856554 0.82 CHRM4 (0.32) CHRM4CHRM3
SCHEMBL1860650 0.78 KDM4E (0.31) CHRM4CHRM3
SCHEMBL1856576 0.73 BCHE (0.35)
SCHEMBL1362081 0.72 S1PR5 (0.41)
SCHEMBL689996 0.72
SCHEMBL1854797 0.72
SCHEMBL1860026 0.68 CHRM3 (0.35) CHRM4CHRM3
SCHEMBL17977290 0.66

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1863475-B1 NOVEL THIOPHENE DERIVATIVES AS SPHINGOSINE-1-PHOSPHATE-1 RECEPTOR AGONISTS ACTELION PHARMACEUTICALS LTD (CH) 2011-09-07 EP claimed
EP-1863787-B1 HYDOGRENATED BENZO[C]THIOPHENE DERIVATIVES AS IMMUNOMODULATORS ACTELION PHARMACEUTICALS LTD (CH) 2011-05-25 EP claimed
EP-1863474-B1 NOVEL THIOPHENE DERIVATIVES AS SPHINGOSINE-1-PHOSPHATE-1 RECEPTOR AGONISTS ACTELION PHARMACEUTICALS LTD (CH) 2008-11-12 EP claimed